Saccharomyces Boulardii as a Probiotic for Children

Marcia L. Buck, Pharm.D., FCCP

Pediatr Pharm. 2009;15(7) 

In This Article



Saccharomyces boulardii (S. boulardii) has been used as a probiotic agent since the 1950s. It has been shown to be useful in the treatment of acute infectious diarrhea, the prevention or treatment of diarrhea associated with antibiotic use, and as an adjunctive therapy for Helicobacter pylori infection. It has also been suggested as a formula supplement for premature infants.[1–4] This issue of Pediatric Pharmacotherapy will describe the studies published to date on S. boulardii in infants and children and provide an overview of the adverse effects and dosing recommendations for this agent in infants, children, and adults.